Cambridge Cancer Genomics (CCG.ai) wins Gold in "Tech Startup of the Year - Software" category at International Business Awards.
Cambridge Cancer Genomics (CCG.ai) welcomes Dr. Philip Beer onto the team as Head of Translational Medicine.
Genomics England and Cambridge Cancer Genomics (CCG.ai) announce a partnership to improve access to, and the effectiveness of, immunotherapies in lung and colorectal cancers
The co-founders of Cambridge Cancer Genomics (CCG.ai) were today named on Forbes’ annual 30 under 30 list, in the field of science and healthcare.
Capital was raised from a host of Silicon Valley investors, including Jerry Yang’s AME Cloud Ventures, Refactor Capital, Romulus Capital and Y Combinator, to support growing clinical operations in the UK, US and Singapore.